[1]
“Treatment of Iraqi People with Hyperkinetic Movement Disorders by Tetrabenazine in Relation to Genetic Polymorphism of CYP450 2D6”, MLU, vol. 20, no. 3, pp. 660–666, Jul. 2020, doi: 10.37506/mlu.v20i3.1476.